Infection control bathing – Gainsborough Specialist Bathrooms to pioneer at Care Show 2021
On stand C32 at the Care Show, Gainsborough Specialist Bathrooms will be demonstrating, through clinical evidence, how its baths with integrated antimicrobial BioCote technology are proven for advanced hygiene and care excellence (NEC, 13–14 October).
Part of the Gainsborough Healthcare Group, Gainsborough Specialist Bathrooms is a 360-degree provider of bathing solutions for the long term and acute care sectors. Its bath manufacturing prowess, built over 30 years, has established its brands as a leading choice for healthcare providers. Gainsborough baths were the first and remain the only bathing solutions to contain integrated BioCote technology which provides 99.9% 24/7 protection against viruses, bacteria and microbes. Through robust testing, this silver-ion additive is proven to combat Influenza H1N1, E.coli, Salmonella and antibiotic-resistant CPE, CRO, CRE, VRE and MRSA. As the need for infection control continues to accelerate due to the pandemic, the need for dependable antimicrobial protection is now more critical than ever before – delivered by Gainsborough.
Results regarding clinical case studies of BioCote will be available on stand C32. Procurement personnel representing care homes, hospitals and rehabilitation facilities will be able to access this material and discuss BioCote effectiveness with senior Gainsborough representatives. The three power-assisted care baths on display, namely the Gentona, Sentes and Ezion, all contain BioCote and provide exceptional hygiene and efficiency. Each model offers specific performance and economic advantages relevant to individual care scenarios – covering a wide-ranging scope of patient and carer requirements and maximising moving and handling efficiency. The presence of BioCote provides peace of mind and can reduce the risk of potential staff sickness and infectious outbreaks.
As a complementary solution for advanced hygiene, BioCote cannot be wiped or worn away like traditional disinfecting fluids; therefore reducing the possibility of cross contamination – critical in high traffic, communal bathing facilities. Its presence also reduces odours and stains whilst strengthening surface durability, so baths deliver greater long-term value.
Peter Eckhardt, CEO, Gainsborough Healthcare Group, comments:
“We all fully appreciate that infection control is absolutely critical. As the sector faces new challenges, Gainsborough believes it has a duty of care as a bath manufacturer to provide solutions that deliver advanced hygiene. This is why we integrate BioCote.”